Fiche centre
Wuxi People's Hospital
Wuxi — China
Essais liés2clinical trials
VilleWuxilocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07764601
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rimegepant | Migraine | Phase 3 | NCT05810038 | A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. | COMPLETED |
| Penpulimab | Cancer | Non applicable | NCT07764601 | RM-MA-PD1 — R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma | NOT_YET_RECRUITING |